Managed Screening Service is an end-to-end screening service that enables institutional investors to submit and receive screenings of their portfolios or universes at pre-determined frequencies, based on client selected criteria.
Latest Insights
Biodiversity in the Balance: Revisiting Portfolio Risks
Green Buildings on the Rise: Why Building Products Matter
Key Benefits and Features
Customised Screening Criteria
Clients have the flexibility to choose from over 2000 screening criteria, based on different investment mandates.
Extensive Coverage Universe
Sustainalytics research covers more than 20,000 global publicly traded companies across multiple sectors and subindustries.
High-Quality
The screening service eliminates the risk of human error by digitizing the receipt, production, and delivery of portfolio screenings.
Scalability
The batch screening capability facilitates the production and delivery of screenings for a selected list of portfolios.
Timely Delivery
The managed screening service supports faster turnaround times aligned with clients’ needs.
Smooth Onboarding
Clients can easily provide the necessary information through the portfolio submission template, sent by email or FTP.
Flexible Delivery Option
Automated on-time delivery via FTP or email.
User-Friendly Output
The screening results are delivered in a simple easy-to-navigate deliverable, which includes a summary of the applied screening criteria.
Implementation
Implement the negative/positive screening strategy to identify the number of companies aligned with regulatory requirements and client’s preferences.
Screen for companies involved in specific products and activities, such as Tobacco, Thermal Coal, Oil Sands, Small Arms.
Identify companies that derive revenue from sustainable products and services, such as Green Transportation and Renewable Energy.
Exclude companies involved in weapons whose use have an indiscriminate and disproportional humanitarian impact on civilians, such as Cluster and Nuclear Weapons.
Eliminate companies that breach international norms and standards, such as the UN Global Compact.
Screen for companies involved in controversies that may pose a business or reputation risk due to the potential impact on stakeholders or the environment.
Analyze portfolio based on other investment considerations such as risk-based ESG scores, percentage of EU Taxonomy-aligned revenues and other relevant E, S and G criteria.
Why Sustainalytics?
A Single Market Standard
Consistent approach to ESG assessments across the investment spectrum.
Award-Winning Research and Data
Firm recognized as Best ESG Research and Data Provider by Environmental Finance and Investment Week.
End-to-End ESG Solutions
ESG products and services that serve the entire investment value chain.
30 Years of ESG Expertise
800+ ESG research analysts across our global offices.
A Leading SPO Provider
As recognized by Environmental Finance and the Climate Bonds Initiative.
Related Insights and Resources
Biodiversity in the Balance: Revisiting Portfolio Risks
On the occasion of COP16, this article updates previous research from Morningstar Sustainalytics showing how investing in companies facing high levels of risk associated with biodiversity loss can have a material effect on long-term portfolio performance.
Why Looks Could Kill: An ESG Perspective on GLP-1 Medications for Cosmetic Weight Loss and Diabetes
GLP-1 medications' proven efficacy for weight loss caused global demand for these treatments to soar. While the heightened demand is promising for biopharmaceutical companies, it also introduces an array of ESG challenges that this article explores.
Additional Ways to Access our Research
API & Datafeed Solutions
Integrate our research directly into your systems and work processes through a variety of data deliverables.
Partner Platforms
Access Sustainalytics’ research through various partner platforms with dedicated functionalities, including Morningstar Direct, Bloomberg, Aladdin, RIMES, Markit, Factset & Style Analytics.
Global Access
Sustainalytics’ online platform enables you to access our research through a user-friendly interface with robust screening, monitoring and reporting tools.